MesoPher

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMesoPher

Drug Alias NameAllogeneic tumour cell lysate pulsed autologous dendritic cellsMesoCancerVacAutologous dendritic cell vaccine (Amphera)

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPancreatic NeoplasmsMesothelioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlandsEU

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesAmphera Bv

China Registration ClassN/A

Develop Information

Active CompaniesAmphera Bv Erasmus Universiteit Rotterdam Erasmus Medical Center

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsMesothelioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A